186 related articles for article (PubMed ID: 8627812)
1. Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals.
Decker LL; Klaman LD; Thorley-Lawson DA
J Virol; 1996 May; 70(5):3286-9. PubMed ID: 8627812
[TBL] [Abstract][Full Text] [Related]
2. Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients.
Babcock GJ; Decker LL; Freeman RB; Thorley-Lawson DA
J Exp Med; 1999 Aug; 190(4):567-76. PubMed ID: 10449527
[TBL] [Abstract][Full Text] [Related]
3. A novel form of Epstein-Barr virus latency in normal B cells in vivo.
Miyashita EM; Yang B; Lam KM; Crawford DH; Thorley-Lawson DA
Cell; 1995 Feb; 80(4):593-601. PubMed ID: 7532548
[TBL] [Abstract][Full Text] [Related]
4. Establishment of latent Epstein-Barr virus infection and stable episomal maintenance in murine B-cell lines.
Haan KM; Aiyar A; Longnecker R
J Virol; 2001 Mar; 75(6):3016-20. PubMed ID: 11222728
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus genomes are found predominantly in IgA-positive B cells in the blood of healthy carriers.
Ehlin-Henriksson B; Zou JZ; Klein G; Ernberg I
Int J Cancer; 1999 Sep; 83(1):50-4. PubMed ID: 10449607
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells.
Sugiura M; Imai S; Tokunaga M; Koizumi S; Uchizawa M; Okamoto K; Osato T
Br J Cancer; 1996 Aug; 74(4):625-31. PubMed ID: 8761381
[TBL] [Abstract][Full Text] [Related]
7. PARP1 Stabilizes CTCF Binding and Chromatin Structure To Maintain Epstein-Barr Virus Latency Type.
Lupey-Green LN; Caruso LB; Madzo J; Martin KA; Tan Y; Hulse M; Tempera I
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976663
[TBL] [Abstract][Full Text] [Related]
8. Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils.
Joseph AM; Babcock GJ; Thorley-Lawson DA
J Virol; 2000 Nov; 74(21):9964-71. PubMed ID: 11024124
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.
Tierney RJ; Steven N; Young LS; Rickinson AB
J Virol; 1994 Nov; 68(11):7374-85. PubMed ID: 7933121
[TBL] [Abstract][Full Text] [Related]
10. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell.
Miyashita EM; Yang B; Babcock GJ; Thorley-Lawson DA
J Virol; 1997 Jul; 71(7):4882-91. PubMed ID: 9188550
[TBL] [Abstract][Full Text] [Related]
11. When Epstein-Barr virus persistently infects B-cell lines, it frequently integrates.
Hurley EA; Agger S; McNeil JA; Lawrence JB; Calendar A; Lenoir G; Thorley-Lawson DA
J Virol; 1991 Mar; 65(3):1245-54. PubMed ID: 1847452
[TBL] [Abstract][Full Text] [Related]
12. Latent and lytic Epstein-Barr virus gene expression in the peripheral blood of astronauts.
Stowe RP; Kozlova EV; Sams CF; Pierson DL; Walling DM
J Med Virol; 2011 Jun; 83(6):1071-7. PubMed ID: 21503923
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus immortalization and latency.
Rowe DT
Front Biosci; 1999 Mar; 4():D346-71. PubMed ID: 10077545
[TBL] [Abstract][Full Text] [Related]
14. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells.
Miller G; Heston L; Grogan E; Gradoville L; Rigsby M; Sun R; Shedd D; Kushnaryov VM; Grossberg S; Chang Y
J Virol; 1997 Jan; 71(1):314-24. PubMed ID: 8985352
[TBL] [Abstract][Full Text] [Related]
15. A new form of Epstein-Barr virus latency in vivo.
Miyashita E; Thorley-Lawson DA
Curr Top Microbiol Immunol; 1995; 194():135-44. PubMed ID: 7895488
[No Abstract] [Full Text] [Related]
16. Chromatin Structure of Epstein-Barr Virus Latent Episomes.
Lieberman PM
Curr Top Microbiol Immunol; 2015; 390(Pt 1):71-102. PubMed ID: 26424644
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?
Longnecker R
Adv Cancer Res; 2000; 79():175-200. PubMed ID: 10818681
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease.
Brousset P; Meggetto F; Chittal S; Bibeau F; Arnaud J; Rubin B; Delsol G
Lab Invest; 1993 Oct; 69(4):483-90. PubMed ID: 8231115
[TBL] [Abstract][Full Text] [Related]
19. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
20. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.
Dheekollu J; Malecka K; Wiedmer A; Delecluse HJ; Chiang AK; Altieri DC; Messick TE; Lieberman PM
Oncotarget; 2017 Jan; 8(5):7248-7264. PubMed ID: 28077791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
